Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines

Hironori Edamatsu, Chia-Ling Gau, Tetsuo Nemoto, Lea Guo, Fuyuhiko Tamanoi

Open source

DOI
10.1038/sj.onc.1203625
Published
2000-06-20
Container
Oncogene
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/sj.onc.1203625,
  title = {Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines},
  author = {Hironori Edamatsu and Chia-Ling Gau and Tetsuo Nemoto and Lea Guo and Fuyuhiko Tamanoi},
  year = {2000},
  journal = {Oncogene},
  doi = {10.1038/sj.onc.1203625},
  url = {https://doi.org/10.1038/sj.onc.1203625}
}

RIS

TY  - JOUR
TI  - Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines
AU  - Hironori Edamatsu
AU  - Chia-Ling Gau
AU  - Tetsuo Nemoto
AU  - Lea Guo
AU  - Fuyuhiko Tamanoi
PY  - 2000
JO  - Oncogene
DO  - 10.1038/sj.onc.1203625
UR  - https://doi.org/10.1038/sj.onc.1203625
ER  - 

APA

Edamatsu, H., Gau, C., Nemoto, T., Guo, L., & Tamanoi, F. (2000). Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines. Oncogene. https://doi.org/10.1038/sj.onc.1203625

Source records